In this current study, we explore whether encapsulating an ATM inhibitor in a TPP-functionalized hyperbranched polyethylenimine nanocarrier can be effective against the mammospheres of drug resistant breast cancer cells—a close analogue to CSCs—without having considerable toxic effects against adherent cells. This evidence concerns the gene ATM and breast cancer.